Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunoprecise Antibodies Ltd (NQ: IPA )

0.4300 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunoprecise Antibodies Ltd

< Previous 1 2 3 4 5 6 7 Next >
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. 
Via Benzinga
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Preview For ImmunoPrecise Antibodies
Via Benzinga
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Via ACCESSWIRE
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words... 
Via Benzinga
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
Via ACCESSWIRE
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently 
Via Benzinga
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024
IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Scheduled For December 14, 2023
Companies Reporting Before The Bell • Live Ventures (NASDAQ:LIVE) is estimated to report earnings for its fourth quarter. • Jabil (NYSE:JBL) is projected to report earnings for its first quarter. 
Via Benzinga
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
Via ACCESSWIRE
Gold Moves Higher; Campbell Soup Earnings Top Expectations
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. 
Via Benzinga
Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Today
ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at 
Via Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
US Stocks Higher; Private Payrolls Rise By 103,000 In November
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Carbon Revolution (CREV) Stock Down Today?
Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call. 
Via InvestorPlace
Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?
ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA. 
Via InvestorPlace
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook. 
Via Benzinga
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning! 
Via InvestorPlace
IPA Announces Pricing of $1.1 Million Public Offering of Common Shares
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Announces Proposed Public Offering of Common Shares
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
Via ACCESSWIRE
ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand®, has launched an advanced Retrieval Augmented... 
Via Benzinga
BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary BioStrand has published a preprint of its white paper titled "New Paradigm for Biological Sequence Retrieval Inspired by Natural 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.